An analysis of first-line disease-modifying therapies in patients with relapsing-remitting multiple sclerosis using the French nationwide health claims database from 2014–2017
Patrick Vermersch, Laurent Suchet, R. Colamarino, Caroline Laurendeau, B. Detournay
Topics & Concepts
MedicineTeriflunomideGlatiramer acetateDiscontinuationDimethyl fumarateMultiple sclerosisInternal medicineRelapsing remittingPopulationFingolimodPediatricsRetrospective cohort studyDiseasePsychiatryEnvironmental healthMultiple Sclerosis Research StudiesRheumatoid Arthritis Research and TherapiesPeripheral Neuropathies and Disorders